August 15, 2022

Genetech’s Xofluza® (baloxavir marboxil) has been approved for the treatment of acute uncomplicated influenza in otherwise healthy children aged five to less than 12 years of age who have been symptomatic for no more than 48 hours.

  • The cost for Xofluza oral tablet 40 mg is around $ 50 for a supply of 1 tablet.
  • Recommended dosing is based on weight and taken as a single dose. 2 mg/kg taken as a single dose 40 mg (20 mL) taken as a single dose 80 mg (40 mL) taken as a single dose.
  • Xofluza first received FDA approval in 2018.
August 18, 2022

U.S. FDA Approves First Cetrotide Generic

Read More
August 17, 2022

Zynteglo Approved as Gene Therapy for Rare Blood Disorder

Read More